Unknown

Dataset Information

0

Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration.


ABSTRACT: The discovery of circulating tumour DNA molecules created a paradigm shift in tumour biomarkers as predictors of recurrence. Non-invasive prenatal testing (NIPT) to detect circulating cell-free foetal DNA in maternal plasma is increasingly recognised as a valuable substitute to perceive foetal copy number variation (CNV). This study aimed to determine whether the copy number detection in plasma samples using NIPT platform could be used as a prognostic biomarker in patients with gynaecological cancer. We conducted a prospective study using samples containing preoperative plasma from 100 women with gynaecological cancers. Samples were randomly rearranged and blindly sequenced using a low-coverage whole-genome sequencing plasma DNA, NIPT platform. The NIPT pipeline identified copy number alterations (CNAs) were counted in plasma as a gain or loss if they exceeded 10?Mb from the expected diploid coverage. Progression-free survival (PFS) and overall survival (OS) were analysed according to the presence of CNA in plasma using Kaplan-Meier analyses. The NIPT pipeline detected 19/100 cases of all gynaecological cancers, including 6/36 ovarian cancers, 3/11 cervical cancers, and 10/53 endometrial cancers. Patients with CNA in plasma had a significantly poorer prognosis in all stages concerning PFS and OS. Therefore, low-coverage sequencing NIPT platform could serve as a predictive marker of patient outcome.

SUBMITTER: Nakabayashi M 

PROVIDER: S-EPMC6060170 | biostudies-other | 2018 Jul

REPOSITORIES: biostudies-other

altmetric image

Publications

Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration.

Nakabayashi Makoto M   Kawashima Akihiro A   Yasuhara Rika R   Hayakawa Yosuke Y   Miyamoto Shingo S   Iizuka Chiaki C   Sekizawa Akihiko A  

Scientific reports 20180725 1


The discovery of circulating tumour DNA molecules created a paradigm shift in tumour biomarkers as predictors of recurrence. Non-invasive prenatal testing (NIPT) to detect circulating cell-free foetal DNA in maternal plasma is increasingly recognised as a valuable substitute to perceive foetal copy number variation (CNV). This study aimed to determine whether the copy number detection in plasma samples using NIPT platform could be used as a prognostic biomarker in patients with gynaecological ca  ...[more]

Similar Datasets

| S-EPMC4992833 | biostudies-literature
| S-EPMC2630795 | biostudies-literature
2008-11-13 | E-GEOD-13373 | biostudies-arrayexpress
2008-11-14 | GSE13373 | GEO
| S-EPMC5564585 | biostudies-other
| S-EPMC3031566 | biostudies-literature
2008-11-13 | E-GEOD-12019 | biostudies-arrayexpress
2008-11-13 | E-GEOD-13372 | biostudies-arrayexpress
| S-EPMC3553135 | biostudies-literature
2008-11-14 | GSE13372 | GEO